Migalastat for treating Fabry disease

Equality Impact Assessment (Guidance development) (PDF 235 KB)

Final evaluation determination

Final evaluation determination document (PDF 417 KB)

Committee papers (PDF 517 KB)

Public committee slides (PDF 252 KB)

Evaluation consultation

Evaluation consultation document (PDF 285 KB)

Committee papers (PDF 7.69 MB)

Equality impact assessment (Scoping) (PDF 122 KB)

Final scope (PDF 109 KB)

Final matrix (PDF 108 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 162 KB)

Draft scope (pre-referral) (PDF 114 KB)

Provisional matrix (pre-referral) (PDF 109 KB)